MiNK Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $17.3M | $34.7M |
| Jun 2022 | — | $13.7M | $29.8M |
| Sep 2022 | — | $6.8M | $24.2M |
| Dec 2022 | — | $-401.3K | $19.6M |
| Mar 2023 | — | $-4.5M | $14.9M |
| Jun 2023 | — | $-9.5M | $10.6M |
| Sep 2023 | — | $-13.6M | $6.4M |
| Dec 2023 | — | $-18.1M | $3.4M |
| Mar 2024 | — | $-20.3M | $5.8M |
| Jun 2024 | — | $-16.6M | $9.3M |
| Sep 2024 | — | $-17.6M | $6.3M |
| Dec 2024 | — | $-19.6M | $4.6M |
| Mar 2025 | — | $-21.8M | $3.2M |
| Jun 2025 | — | $-25.2M | $1.7M |
| Sep 2025 | — | $-13.5M | $9.5M |
| Dec 2025 | — | $-14.2M | $13.4M |
| Mar 2026 | — | $-12.7M | $9.5M |
| Jun 2026 | — | $-14.0M | $8.8M |